Aberrant PD-1 ligand expression contributes to the myocardial inflammatory injury caused by Coxsackievirus B infection
Authors/Creators
Tianying Wang
Shuang Chen
Xueqing Wang Wang, Edith Cowan UniversityFollow
Yike Huang
Jianfa Qiu
Yanru Fei
Anita Chaulagain
Yang Chen
Yan Wang
Lexun Lin
Biying Yan
Ying Wang
Wei Wang, Edith Cowan UniversityFollow
Wenran Zhao
Zhaohua Zhong
Abstract
Coxsackievirus group B (CVB) is considered as one of the most common pathogens of human viral myocarditis. CVB-induced myocarditis is mainly characterized by the persistence of the virus infection and immune-mediated inflammatory injury. Costimulatory signals are crucial for the activation of adaptive immunity. Our data reveal that the CVB type 3 (CVB3) infection altered the expression profile of costimulatory molecules in host cells. CVB3 infection caused the decrease of PD-1 ligand expression, partially due to the cleavage of AU-rich element binding protein AUF1 by the viral protease 3C pro , leading to the exacerbated inflammatory injury of the myocardium. Moreover, systemic PD-L1 treatment, which augmented the apoptosis of proliferating lymphocytes, alleviated myocardial inflammatory injury. Our findings suggest that PD1-pathway can be a potential immunologic therapeutic target for CVB-induced myocarditis. © 2019 Elsevier B.V.
RAS ID
28490
Document Type
Journal Article
Date of Publication
1-1-2019
School
School of Medical and Health Sciences
Copyright
subscription content
Publisher
Elsevier BV
Recommended Citation
Wang, T., Chen, S., Wang, X., Huang, Y., Qiu, J., Fei, Y., Chaulagain, A., Chen, Y., Wang, Y., Lin, L., Yan, B., Wang, Y., Wang, W., Zhao, W., & Zhong, Z. (2019). Aberrant PD-1 ligand expression contributes to the myocardial inflammatory injury caused by Coxsackievirus B infection. DOI: https://doi.org/10.1016/j.antiviral.2019.03.007
Comments
Wang, T., Chen, S., Wang, X., Huang, Y., Qiu, J., Fei, Y., . . . Zhong, Z. (2019). Aberrant PD-1 ligand expression contributes to the myocardial inflammatory injury caused by coxsackievirus B infection. Antiviral Research, 166, 1-10. Available here